Hong Kong-listed biotech shares rose, led by Duality Biotherapeutics-B (02617.HK), which climbed more than 20%.
According to Jin10, Hua Medicine (02552.HK) gained more than 7%, while XtalPi Holdings (02228.HK) and Joinn Laboratories (06127.HK) also moved higher.
STOCKS | Hong Kong Biotech Stocks Rise as Duality Biotherapeutics Jumps Over 20%
2026-06-29 09:48:56
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
